2000
DOI: 10.1016/s0960-9822(00)00778-8
|View full text |Cite
|
Sign up to set email alerts
|

Synaptojanin 2, a novel Rac1 effector that regulates clathrin-mediated endocytosis

Abstract: The small GTPase Rac has been implicated in a wide range of cellular processes, including the organization of the actin cytoskeleton, transcriptional control and endocytic vesicle trafficking [1-3]. The signaling components that mediate these functions downstream of Rac largely remain to be identified. In this study, we have identified synaptojanin 2, a polyphosphoinositide phosphatase as a novel Rac1 effector. Synaptojanin 2 directly and specifically interacts with Rac1 in a GTP-dependent manner. Expression o… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

3
115
0
1

Year Published

2001
2001
2009
2009

Publication Types

Select...
6
2

Relationship

0
8

Authors

Journals

citations
Cited by 131 publications
(119 citation statements)
references
References 13 publications
3
115
0
1
Order By: Relevance
“…However, expression of dominant-negative mutants of these signalling proteins had no effect on receptor uptake in intact cells, suggesting that the observed effects of constitutively active Rac and RhoA may be an indirect consequence of locking these proteins in the active conformation. Symons and co-workers [50] have extended these studies by showing that activated Rac binds directly to the PtdIns(4,5)P # phosphatase synaptojanin 2 and recruits it to cell membranes. Localized concentrations of PtdIns(4,5)P # act as nucleation sites for endocytosis at the plasma membrane, recruiting clathrin and accessory proteins [51].…”
Section: Rhoa and Racmentioning
confidence: 95%
See 1 more Smart Citation
“…However, expression of dominant-negative mutants of these signalling proteins had no effect on receptor uptake in intact cells, suggesting that the observed effects of constitutively active Rac and RhoA may be an indirect consequence of locking these proteins in the active conformation. Symons and co-workers [50] have extended these studies by showing that activated Rac binds directly to the PtdIns(4,5)P # phosphatase synaptojanin 2 and recruits it to cell membranes. Localized concentrations of PtdIns(4,5)P # act as nucleation sites for endocytosis at the plasma membrane, recruiting clathrin and accessory proteins [51].…”
Section: Rhoa and Racmentioning
confidence: 95%
“…After internalization, PtdIns(4,5)P # on clathrin-coated vesicles is hydrolysed by synaptojanin, allowing uncoating of the vesicle and the formation of early endosomes [52]. Fusion of synaptojanin to a membrane targeting motif blocks epidermal-growth-factor (EGF)-receptor internalization [50], suggesting that constitutively active mutants of Rac may block endocytosis by recruiting synaptojanin to the plasma membrane and depleting PtdIns(4,5)P # at endocytic sites -but what does this say about how Rac acts in i o ? Rac is also able to stimulate synthesis of PtdIns(4,5)P # through activation of type I PtdIns4P 5-kinases [18,53].…”
Section: Rhoa and Racmentioning
confidence: 99%
“…There is a correlation in both time and space between the formation of endocytic vesicles and the reorganization of the actin cytoskeleton (107,214,327,380,382). In S. cerevisiae, where clathrin is not required for endocytosis, actin plays a crucial role (245).…”
Section: A Ptdins(45)p 2 At the Plasma Membranementioning
confidence: 99%
“…Next, proteins were blotted on nitrocellulose membranes and the presence of Syn 2 was shown using specific polyclonal antibodies. 21 binding to such proteins both Syn 1 and Syn 2 probably are involved in various normal and pathogenic pathways. By binding to Grb-2, a member of a family of adaptor proteins that couple receptor tyrosine kinases to the Ras signaling pathway, Syn 2 plays an important role in regulating actin filaments by controlling PtdIns 4,5-P2 levels bound to cytoskeleton-regulating molecules.…”
Section: Discussionmentioning
confidence: 99%
“…Syn 2 was visualized by the Syn 2-specific polyclonal Ab, 21 kindly provided by Dr M Symon (Onyx Pharmaceuticals, Richmond, CA, USA).…”
Section: Western Blot Analysismentioning
confidence: 99%